Novel insights in SHBG regulation and clinical implications

Trends in Endocrinology and Metabolism

Volumn 26, Issue 7, 2015, Pages 376-383

  Simó, Rafael ^a   Sáez López, Cristina ^a   Barbosa Desongles, Anna ^a   Hernández, Cristina ^a   Selva, David M ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Cytokines; Insulin; Sex hormone binding globulin

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; INSULIN; INTERLEUKIN 1BETA; SEX HORMONE BINDING GLOBULIN; MONOSACCHARIDE; PALMITIC ACID DERIVATIVE;

ANOREXIA; BODY MASS; DOWN REGULATION; FAT CONTENT; HORMONAL REGULATION; HUMAN; LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; THYROID DISEASE; METABOLISM;

BIOMARKERS; HUMANS; INSULIN; INTERLEUKIN-1BETA; LIVER; MONOSACCHARIDES; OBESITY; PALMITATES; SEX HORMONE-BINDING GLOBULIN;

EID: 84937518300     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2015.05.001     Document Type: Review

References (80)

1. Pugeat M., et al. Sex hormone-binding globulin gene expression in the liver: drugs and the metabolic syndrome. Mol. Cell. Endocrinol. 2010, 316:53-59.
2. Glass A.R., et al. Low serum testosterone and sex-hormone-binding-globulin in massively obese men. J. Clin. Endocrinol. Metab. 1977, 45:1211-1219.
3. Stefan N., et al. Sex hormone-binding globulin and risk of type 2 diabetes. N. Engl. J. Med. 2009, 361:2675-2676. author reply 2677-2678.
4. Peter A., et al. Relationships of circulating sex hormone-binding globulin with metabolic traits in humans. Diabetes 2010, 59:3167-3173.
5. Laaksonen D.E., et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004, 27:1036-1041.
6. Kalme T., et al. Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men. J. Clin. Endocrinol. Metab. 2005, 90:1550-1556.
7. Ding E.L., et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N. Engl. J. Med. 2009, 361:1152-1163.
8. Haffner S.M., et al. Decreased sex hormone-binding globulin predicts noninsulin-dependent diabetes mellitus in women but not in men. J. Clin. Endocrinol. Metab. 1993, 77:56-60.
9. Lindstedt G., et al. Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-year follow-up of population study of women in Gothenburg, Sweden. Diabetes 1991, 40:123-128.
10. Sutton-Tyrrell K., et al. Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 2005, 111:1242-1249.
11. Haffner S.M., et al. Association of decreased sex hormone binding globulin and cardiovascular risk factors. Arteriosclerosis 1989, 9:136-143.
12. Lapidus L., et al. Concentrations of sex-hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular disease and overall mortality in postmenopausal women. Clin. Chem. 1986, 32:146-152.
13. Pugeat M., et al. Clinical utility of sex hormone-binding globulin measurement. Horm. Res. 1996, 45:148-155.
14. Barbe P., et al. Sex-hormone binding globulin and protein-energy malnutrition indexes as indicators of nutritional status in women with anorexia nervosa. Am. J. Clin. Nutr. 1993, 57:319-322.
15. Anderson D.C. Sex-hormone-binding globulin. Clin. Endocrinol. 1974, 3:69-96.
16. Negri P., et al. Changes in plasma levels of androgens and SHBG in patients with polycystic ovary syndrome (PCOS) treated with oral contraceptives containing desogestrel. Minerva Ginecol. 1988, 40:699-707.
17. Manusharova R.A. Plasma level of testosterone-estradiol-binding globulin in women with Itsenko-Cushing disease. Probl. Endokrinol. (Mosk.) 1986, 32:11-13.
18. Holly J.M., et al. Inter-relations between growth hormone, insulin, insulin-like growth factor-I (IGF-I), IGF-binding protein-1 (IGFBP-1) and sex hormone-binding globulin in acromegaly. Clin. Endocrinol. (Oxf.) 1991, 34:275-280.
19. Niskanen L., et al. Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome. Diabetes Obes. Metab. 2004, 6:208-215.
20. Shin J.Y., et al. Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in people with type 2 diabetes. Diabetes Res. Clin. Pract. 2011, 94:156-162.
21. Norman R.J., et al. Polycystic ovary syndrome. Lancet 2007, 370:685-697.
22. Le T.N., et al. Sex hormone-binding globulin and type 2 diabetes mellitus. Trends Endocrinol. Metab. 2012, 23:32-40.
23. Bonnet F., et al. Sex hormone-binding globulin predicts the incidence of hyperglycemia in women: interactions with adiponectin levels. Eur. J. Endocrinol. 2009, 161:81-85.
24. Perry J.R., et al. Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduces the risk of type 2 diabetes. Hum. Mol. Genet. 2010, 19:535-544.
25. Li C., et al. Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men. Diabetes Care 2010, 33:1618-1624.
26. Stefan N., et al. Comment on Hedderson et al. Prepregnancy SHBG concentrations and risk for subsequently developing gestational diabetes mellitus. Diabetes Care 2014 2014, 37:1296-1303. Diabetes Care 37, e278-e279.
27. Wallace I.R., et al. Sex hormone binding globulin and insulin resistance. Clin. Endocrinol. (Oxf.) 2013, 78:321-329.
28. Stefan N., et al. The role of hepatokines in metabolism. Nat. Rev. Endocrinol. 2013, 9:144-152.
29. Sarne D.H., et al. Sex hormone-binding globulin in the diagnosis of peripheral tissue resistance to thyroid hormone: the value of changes after short term triiodothyronine administration. J. Clin. Endocrinol. Metab. 1988, 66:740-746.
30. Raggatt L.E., et al. Effects of thyroid hormone on sex hormone-binding globulin gene expression in human cells. J. Clin. Endocrinol. Metab. 1992, 75:116-120.
31. Selva D.M., Hammond G.L. Thyroid hormones act indirectly to increase sex hormone-binding globulin production by liver via hepatocyte nuclear factor-4α. J. Mol. Endocrinol. 2009, 43:19-27.
32. Mirone L., et al. A study of serum androgen and cortisol levels in female patients with rheumatoid arthritis. Correlation with disease activity. Clin. Rheumatol. 1996, 15:15-19.
33. Yasui T., et al. Associations of adiponectin with sex hormone-binding globulin levels in aging male and female populations. Clin. Chim. Acta 2007, 386:69-75.
34. Gannagé-Yared M.H., et al. Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. Eur. J. Endocrinol. 2006, 155:167-176.
35. Simó R., et al. Potential role of tumor necrosis factor-α in downregulating sex hormone-binding globulin. Diabetes 2012, 61:372-382.
36. Simó R., et al. Molecular mechanism of TNFα-induced down-regulation of SHBG expression. Mol. Endocrinol. 2012, 26:438-446.
37. Carlström K., et al. Endocrine effects of the podophyllotoxine derivative drug CPH 82 (Reumacon) in patients with rheumatoid arthritis. Scand. J. Rheumatol. 2000, 29:89-94.
38. Sattar N., et al. Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: a double-blind, placebo-controlled study. Arthritis Rheum. 2007, 56:831-839.
39. Simó R., et al. IL1β down-regulation of sex hormone-binding globulin production by decreasing HNF-4α via MEK-1/2 and JNK MAPK pathways. Mol. Endocrinol. 2012, 26:1917-1927.
40. Kadowaki T., Yamauchi T. Adiponectin and adiponectin receptors. Endocr. Rev. 2005, 26:439-451.
41. Viollet B., et al. AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiol. (Oxf.) 2009, 196:81-98.
42. Arita Y., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 1999, 257:79-83.
43. Simó R., et al. Adiponectin upregulates SHBG production: molecular mechanisms and potential implications. Endocrinology 2014, 155:2820-2830.
44. Plymate S.R., et al. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J. Clin. Endocrinol. Metab. 1988, 67:460-464.
45. Moran L.J., et al. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. Update 2010, 16:347-363.
46. Veldhuis J.D., et al. Immunological and mass spectrometric assays of SHBG: consistent and inconsistent metabolic associations in healthy men. J. Clin. Endocrinol. Metab. 2014, 99:184-193.
47. Danielson K.K., et al. Sex hormone-binding globulin and testosterone in individuals with childhood diabetes. Diabetes Care 2008, 31:1207-1213.
48. Crave J.C., et al. Differential effects of insulin and insulin-like growth factor I on the production of plasma steroid-binding globulins by human hepatoblastoma-derived (Hep G2) cells. J. Clin. Endocrinol. Metab. 1995, 80:1283-1289.
49. Loukovaara M., et al. Regulation of production and secretion of sex hormone-binding globulin in HepG2 cell cultures by hormones and growth factors. J. Clin. Endocrinol. Metab. 1995, 80:160-164.
50. Selva D.M., et al. Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene. J. Clin. Invest. 2007, 117:3979-3987.
51. Jhun H., et al. IL-32γ overexpression accelerates streptozotocin (STZ)-induced type 1 diabetes. Cytokine 2014, 69:1-5.
52. Nestler J.E., et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 1991, 72:83-89.
53. Pasquali R., et al. Effects of acute hyperinsulinemia on testosterone serum concentrations in adult obese and normal-weight men. Metabolism 1997, 46:526-529.
54. Liu X., et al. The regulation of rotenone-induced inflammatory factor production by ATP-sensitive potassium channel expressed in BV-2 cells. Neurosci. Lett. 2006, 394:131-135.
55. Xu B., et al. Antihypertensive drugs clonidine, diazoxide, hydralazine and furosemide regulate the production of cytokines by placentas and peripheral blood mononuclear cells in normal pregnancy. J. Hypertens. 2006, 24:915-922.
56. + channel opener on liver ischemia/reperfusion injury. World J. Gastroenterol. 2014, 20:15319-15326.
57. ATP channels inhibits rotenone-induced neuroinflammation. J. Cell. Mol. Med. 2008, 12:1559-1570.
58. Tong G., et al. Intensive insulin therapy increases SHBG in newly diagnosed type 2 diabetic patients. Eur. J. Endocrinol. 2014, 170:237-245.
59. York L.W., et al. Nonalcoholic fatty liver disease and low-carbohydrate diets. Annu. Rev. Nutr. 2009, 29:365-379.
60. Winters S.J., et al. Sex hormone-binding globulin gene expression and insulin resistance. J. Clin. Endocrinol. Metab. 2014, 99:E2780-E2788.
61. Sáez-López C., et al. Oleic acid increases hepatic sex hormone binding globulin production in men. Mol. Nutr. Food Res. 2014, 58:760-767.
62. Soriguer F., et al. Testosterone, SHBG and risk of type 2 diabetes in the second evaluation of the Pizarra cohort study. Eur. J. Clin. Invest. 2012, 42:79-85.
63. Kapoor D., et al. Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with type 2 diabetes. Diab. Vasc. Dis. Res. 2008, 5:135-137.
64. van den Berghe G., et al. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. J. Clin. Endocrinol. Metab. 2001, 86:3217-3226.
65. Chesnokova V., Melmed S. Minireview: neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules. Endocrinology 2002, 143:1571-1574.
66. Kalyani R.R., et al. Male hypogonadism in systemic disease. Endocrinol. Metab. Clin. North Am. 2007, 36:333-348.
67. Tengstrand B., et al. Gonadal hormones in men with rheumatoid arthritis - from onset through 2 years. J. Rheumatol. 2009, 36:887-892.
68. Oktenli C., et al. Transient hypogonadotrophic hypogonadism in males with acute toxoplasmosis: suppressive effect of interleukin-1 beta on the secretion of GnRH. Hum. Reprod. 2004, 19:859-866.
69. Nettleship J.E., et al. Inverse relationship between serum levels of interleukin-1β and testosterone in men with stable coronary artery disease. Horm. Metab. Res. 2007, 39:366-371.
70. Whitacre C.C. Sex differences in autoimmune disease. Nat. Immunol. 2001, 2:777-780.
71. Malkin C.J., et al. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J. Clin. Endocrinol. Metab. 2004, 89:3313-3318.
72. Lin Y.M., et al. Activation of estrogen receptors with E2 downregulates peroxisome proliferator-activated receptor γ in hepatocellular carcinoma. Oncol. Rep. 2013, 30:3027-3031.
73. Nishizawa H., et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002, 51:2734-2741.
74. López-Miranda J., et al. Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008. Nutr. Metab. Cardiovasc. Dis. 2010, 20:284-294.
75. Joseph D.R. Structure, function, and regulation of androgen-binding protein/sex hormone-binding globulin. Vitam. Horm. 1994, 49:197-280.
76. Selva D.M., Hammond G.L. Human sex hormone-binding globulin is expressed in testicular germ cells and not in Sertoli cells. Horm. Metab. Res. 2006, 38:230-235.
77. Pinós T., et al. Identification, characterization and expression of novel sex hormone binding globulin alternative first exons in the human prostate. BMC Mol. Biol. 2009, 10:59.
78. Jänne M., Hammond G.L. Hepatocyte nuclear factor-4 controls transcription from a TATA-less human sex hormone-binding globulin gene promoter. J. Biol. Chem. 1998, 273:34105-34114.
79. Hammond G.L. Diverse roles for sex hormone-binding globulin in reproduction. Biol. Reprod. 2011, 85:431-441.
80. Jänne M., et al. Human sex hormone-binding globulin gene expression in transgenic mice. Mol. Endocrinol. 1998, 12:123-136.